Multiple myeloma usually affects older adults. However, younger patients constitute a
significant subset as approximately 10% of cases occur in subjects younger than 50 years …

Serum monoclonal immunoglobulin (Ig) is the main diagnostic factor for patients with
multiple myeloma (MM), however its prognostic potential remains unclear. On a large MM …

Introduction Monoclonal antibody light chain proteins secreted by clonal plasma cells cause
tissue damage due to amyloid deposition and other mechanisms. The unique protein …

Background Detection of free light chains (fLC) in animals relies on protein electrophoresis
or the Bence‐Jones protein test on urine. Objective To describe the detection of both serum …

Objectives This study aimed to investigate real‐world data of ixazomib plus lenalidomide
and dexamethasone (IRd) therapy for patients with relapsed and refractory multiple …

Introduction: Multiple myeloma (MM) is uncommon in persons younger than 50 years of age.
The presenting features in this age group are unclear. Methods: We analyzed a cohort of …

PURPOSE The gold standard for monitoring response status in patients with multiple
myeloma (MM) is serum and urine protein electrophoresis which quantify M-spike proteins; …

Objectives Autologous hematopoietic stem cell transplantation (ASCT) is a crucial method
used in patients with multiple myeloma (MM). This study aims to evaluate the role of ASCT in …

Serum electrophoresis (SPEP) is a method used to analyze the distribution of the most
important proteins in the blood. The major clinical question is the presence of monoclonal …

Multiple myeloma (MM) is a neoplasm characterized by malignant proliferation of plasma
cells that produce excessive quantities of a single type of immunoglobulin (Ig) called as …